3,4-dihydroxyphenylacetic acid has been researched along with Asphyxia in 3 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Asphyxia: A pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One of the most important manifestations of perinatal asphyxia is the occurrence of seizures, which are treated with antiepileptic drugs, such as carbamazepine." | 7.81 | Effect of perinatal asphyxia and carbamazepine treatment on cortical dopamine and DOPAC levels. ( López-Pérez, SJ; Medina-Ceja, L; Morales-Villagrán, A, 2015) |
| "One of the most important manifestations of perinatal asphyxia is the occurrence of seizures, which are treated with antiepileptic drugs, such as carbamazepine." | 3.81 | Effect of perinatal asphyxia and carbamazepine treatment on cortical dopamine and DOPAC levels. ( López-Pérez, SJ; Medina-Ceja, L; Morales-Villagrán, A, 2015) |
| "The present study was undertaken in order to study the effects of perinatal asphyxia on tyrosine hydroxylase (TH) activity, dopamine levels and turnover, and dopamine metabolites (3,4-dihydroxyphenylacetic acid, DOPAC, homovanillic acid, HVA, and 3-methoxytyramine, 3-MT, analyzed by high-performance liquid chromatography, HPLC) measured in the basal ganglia of the 20- to 40-min-old newborn and 4-week-old male rat." | 3.69 | Effects of perinatal asphyxia on the mesostriatal/mesolimbic dopamine system of neonatal and 4-week-old male rats. ( Andersson, K; Bjelke, B; Bolme, P; Chen, Y; Eneroth, P; Gross, J; Heldt, J; Herrera-Marschitz, M; Loidl, CF; Ungethüm, U, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Pérez, SJ | 1 |
| Morales-Villagrán, A | 1 |
| Medina-Ceja, L | 1 |
| Ungethüm, U | 1 |
| Chen, Y | 1 |
| Gross, J | 1 |
| Bjelke, B | 1 |
| Bolme, P | 1 |
| Eneroth, P | 1 |
| Heldt, J | 1 |
| Loidl, CF | 1 |
| Herrera-Marschitz, M | 1 |
| Andersson, K | 1 |
| Endo, T | 1 |
| Hara, S | 1 |
| Kuriiwa, F | 1 |
| Kano, S | 1 |
3 other studies available for 3,4-dihydroxyphenylacetic acid and Asphyxia
| Article | Year |
|---|---|
Effect of perinatal asphyxia and carbamazepine treatment on cortical dopamine and DOPAC levels.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Asphyxia; Carbamazepine; Dopamine; Frontal | 2015 |
Effects of perinatal asphyxia on the mesostriatal/mesolimbic dopamine system of neonatal and 4-week-old male rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Asphyxia; Basal Ganglia; Dopamine; Female | 1996 |
Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Asphyxia; Cause of Death; Chromatogr | 1990 |